KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $23 | $19 | $17 | $15 |
| % Growth | 16.5% | 12.4% | 14.2% | – |
| Cost of Goods Sold | $11 | $11 | $10 | $9 |
| Gross Profit | $11 | $9 | $8 | $7 |
| % Margin | 50.6% | 45.7% | 44.3% | 43.4% |
| R&D Expenses | $5 | $4 | $5 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38 | $34 | $50 | $24 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $43 | $38 | $56 | $27 |
| Operating Income | -$32 | -$29 | -$48 | -$21 |
| % Margin | -140.7% | -149.1% | -279.8% | -136.5% |
| Other Income/Exp. Net | -$1 | $3 | -$3 | -$1 |
| Pre-Tax Income | -$33 | -$26 | -$51 | -$22 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$33 | -$26 | -$52 | -$22 |
| % Margin | -145.3% | -133.3% | -302.1% | -142.5% |
| EPS | -0.64 | -0.5 | -2.21 | -0.5 |
| % Growth | -28% | 77.4% | -342% | – |
| EPS Diluted | -0.64 | -0.5 | -2.21 | -0.5 |
| Weighted Avg Shares Out | 51 | 51 | 50 | 50 |
| Weighted Avg Shares Out Dil | 51 | 51 | 50 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $1 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$28 | -$22 | -$47 | -$18 |
| % Margin | -126.2% | -112.8% | -275.1% | -119.7% |